Global Allergy Treatment Market is valued approximately USD 17.44 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.48% over the forecast period 2021-2027. Allergy treatment has grown immensely, looking into the fact that a significant portion of the population worldwide is suffering from some type of allergy or the other. It may be food, eye, rhinitis asthma, or skin allergies. Increasing investments from the private players and increasing incidences of various allergies and respiratory problems are factors contributing to the market growth. For instance: in the year 2018, according to Medscape, about 10%-30% adults and 40% of children suffered from allergic rhinitis. However, increasing use of biosimilars and lack of awareness towards Allergy Immunotherapy (AIT) in the patients impedes the growth of the market over the forecast period of 2021-2027. Also, increasing awareness towards health and self-medication and rapid technological advancements is likely to increase the growth of the market in the forecasting period.

The regional analysis of global Allergy Treatment market when considering for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World has led to the analysis that North America is a significant region across the world in terms of market share owing to increasing number of food and rhinitis allergy Whereas, Asia Pacific is anticipated to exhibit highest growth rate over the forecast period 2021-2027. Factors such as increasing investments would create lucrative growth prospects for the Allergy Treatment market across Asia-Pacific region.

Major market player included in this report are:
ALK-Abello A/S
Leti Pharma
Johnson & Johnson
GlaxoSmithKline PLC
Nicox SA
F. Hoffmann-La Roche Ltd
Alembic Pharmaceuticals Limited
Bausch Health Companies Inc.
Allergy Therapeutics
AbbVie Inc.


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By type:
Eye Allergy
Rhinitis
Asthma
Skin Allergy
Food Allergy
Other Allergies
By Treatment:
Anti-Allergy Drugs
Immunotherapy
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Allergy Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors